Insider NameBuy/SellCompany NameTickerAmountShares Change
Dec 23, 2024Dec 23, 2024New Enterprise Associates 16, L.P.
10%
BuyMarker Therapeutics, Inc.MRKR$3.2$2M+25.43%
May 24, 2022May 26, 2022New Enterprise Associates 16, L.P.
10%
SellGenocea Biosciences, Inc.GNCA$0.07$750,662-0
Apr 11, 2022Apr 13, 2022New Enterprise Associates 16, L.P.
10%
BuyTrevi Therapeutics, Inc.TRVI$1.9$5M+20.16%
Dec 10, 2021Dec 27, 2021New Enterprise Associates 16, L.P.
10%
SellMetacrine, Inc.MTCR$0.99$494,483-16.25%
Oct 18, 2021Oct 20, 2021New Enterprise Associates 16, L.P.
10%
BuyTrevi Therapeutics, Inc.TRVI~$0+19.21%
Mar 16, 2021Mar 18, 2021New Enterprise Associates 16, L.P.
10%
BuyMarker Therapeutics, Inc.MRKR$1.75$10M+34.78%
Sep 18, 2020Sep 22, 2020New Enterprise Associates 16, L.P.
10%
BuyMetacrine, Inc.MTCR$13$10M+20.09%
Jul 24, 2020Jul 28, 2020New Enterprise Associates 16, L.P.
10%
BuyGenocea Biosciences, Inc.GNCA$2.25$7M+23.29%
Jun 30, 2020Jul 01, 2020New Enterprise Associates 16, L.P.
10%
BuyAkouos, Inc.AKUS$17$10M+12.05%
Apr 03, 2020Apr 14, 2020New Enterprise Associates 16, L.P.
10%
SellTrevi Therapeutics, Inc.TRVI$2.66$1,500-0.01%
Jul 22, 2019Jul 24, 2019New Enterprise Associates 16, L.P.
10%
BuyMirum Pharmaceuticals, Inc.MIRM$15$7M+9.71%
Jun 24, 2019Jun 25, 2019New Enterprise Associates 16, L.P.
10%
BuyGenocea Biosciences, Inc.GNCA$3.5$10M+28.34%
May 09, 2019May 13, 2019New Enterprise Associates 16, L.P.
10%
BuyTrevi Therapeutics, Inc.TRVI$10$25M+36.03%
Feb 14, 2019Feb 19, 2019New Enterprise Associates 16, L.P.
10%
BuyGenocea Biosciences, Inc.GNCA$0.47$5M+22.16%
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.